Vyome Holdings (HIND) Current Taxes (2019 - 2025)
Vyome Holdings (HIND) posted quarterly Current Taxes of $211000.0 for Q1 2025, up 305.77% year-over-year from $52000.0 in Q1 2024, and up 603.33% quarter-over-quarter from $30000.0 in Q4 2024.
Vyome Holdings (HIND) Current Taxes (2019 - 2025) Analysis & Trends
Vyome Holdings' Current Taxes history runs 7 years deep, the most recent figure standing at $211000.0 for Q1 2025.
- In Q1 2025, Current Taxes rose 305.77% year-over-year to $211000.0; the TTM figure through Mar 2025 stood at $211000.0 (up 305.77% YoY), while the FY2024 annual figure was $30000.0, down 50.82% from the prior year.
- Current Taxes for Q1 2025 stood at $211000.0, up from $30000.0 in the prior quarter.
- The five-year high for Current Taxes was $455000.0 in Q2 2021, with the low at $30000.0 in Q4 2024.
- The 5-year median for Current Taxes is $119500.0 (2022), against an average of $168375.0.
- The sharpest annual moves came in 2023 and 2025: Current Taxes sank 69.19% in 2023, then soared 305.77% in 2025.
- Vyome Holdings' Current Taxes stood at $326000.0 in 2021, then tumbled by 63.5% to $119000.0 in 2022, then sank by 48.74% to $61000.0 in 2023, then tumbled by 50.82% to $30000.0 in 2024, then surged by 603.33% to $211000.0 in 2025.
- Business Quant data shows HIND's Current Taxes at $211000.0 in Q1 2025, $30000.0 in Q4 2024, and $44000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | - |
| 10 | Vyome Holdings | 16.04 Mn | 8.15 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Sep 30, 2022 | 120,000.00 |
| Jun 30, 2022 | 190,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 326,000.00 |
| Sep 30, 2021 | 388,000.00 |
| Jun 30, 2021 | 455,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Dec 31, 2019 | 107,000.00 |